Cited by 163TGF-β signaling in diseasesProtease and Inhibitor MechanismsMechanisms of cancer metastasis

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Cystatin C Antagonizes Transforming Growth Factor β Signaling in Normal and Cancer Cells

Sokol, Jonathan P., Schiemann, William P.·2004·Molecular Cancer Research

Open this paper in CoChat — free account

Abstract

Cystatin C (CystC) is a secreted cysteine protease inhibitor that regulates bone resorption, neutrophil chemotaxis, and tissue inflammation, as well as resistance to bacterial and viral infections. CystC is ubiquitously expressed and present in most bodily fluids where it inhibits the activities of cathepsins, a family of cysteine proteases that can promote cancer cell invasion and metastasis. Transforming growth factor β (TGF-β) is a multifunctional cytokine endowed with both tumor-suppressing and tumor-promoting activities. We show herein that TGF-β treatment up-regulated CystC transcript and protein in murine 3T3-L1 fibroblasts. Moreover, CystC mRNA expression was down-regulated in ∼50% of human malignancies, particularly cancers of the stomach, uterus, colon, and kidney. Overexpression of CystC in human HT1080 fibrosarcoma cells antagonized their invasion through synthetic basement membranes in part via a cathepsin-dependent pathway. Independent of effects on cathepsin activity, CystC also reduced HT1080 cell gene expression stimulated by TGF-β. Invasion of 3T3-L1 cells occurred through both cathepsin- and TGF-β-dependent pathways. Both pathways were blocked by CystC, but only the TGF-β-dependent pathway was blocked by a CystC mutant (i.e., Δ14CystC) that is impaired in its ability to inhibit cathepsin activity. Moreover, CystC and Δ14CystC both inhibited 3T3-L1 cell gene expression stimulated by TGF-β. We further show that CystC antagonized TGF-β binding to its cell surface receptors, doing so by interacting physically with the TGF-β type II receptor and antagonizing its binding of TGF-β. Collectively, our findings have identified CystC as a novel TGF-β receptor antagonist, as well as a novel CystC-mediated feedback loop that inhibits TGF-β signaling.

Integrity signals

Registry

Crossref · 10.1158/1541-7786.183.2.3

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,453
Self-citation
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,391
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,330
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
How cells read TGF-β signals
Massagué, J. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043051 · Cited by 1,925
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J. M., Zentella‐Dehesa, A., Doody, J. F., Laiho, M., Wang, X.-F., & Massagué, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,528
Lysosomal cysteine proteases: more than scavengers
Turk, B., Turk, D., & Türk, V. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00263-0 · Cited by 844
Cystatin C: An Improved Estimator of Glomerular Filtration Rate?
Laterza, O., Price, C. P., & Scott, M. G. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.5.699 · Cited by 658
The 2.0 A X‐ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases.
Bode, W., Engh, R. A., Müsil, D., Thiele, U., Huber, R., Karshikov, A., Brzin, J., Kos, J., & Türk, V. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03109.x · Cited by 594
Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation
Elenbaas, B., & Weinberg, R. A. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5133 · Cited by 572

Show all 60 references

Research works printed but not linked: 4

Kos J, Krasovec M, Cimerman N, Nielsen HJ, Christensen IJ, Brunner N. Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis. Clin Cancer Res, 2000;6:505–11.
Szpaderska AM, Frankfater A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res, 2001;61:3493–500.
Rowland-Goldsmith MA, Maruyama H, Kusama T, Ralli S, Korc M. Soluble type II transforming growth factor-β (TGF-β) receptor inhibits TGF-β signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation. Clin Cancer Res, 2001;7:2931–40.
Won J, Kim H, Park EJ, Hong Y, Kim SJ, Yun Y. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor β receptor therapy. Cancer Res, 1999;59:1273–7.

Sorted by citations

multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1949 · Cited by 1,303
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 664
Cystatins: Biochemical and structural properties, and medical relevance
Türk, V. (2008) · Frontiers in bioscience · doi:10.2741/3089 · Cited by 361
Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors
Wang, B., Sun, J., Kitamoto, S., Yang, M., GRUBB, A. O., Chapman, H. A., Kalluri, R., & Shi, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509134200 · Cited by 295
A Helminth Immunomodulator Reduces Allergic and Inflammatory Responses by Induction of IL-10-Producing Macrophages
Schnoeller, C., Rausch, S., Pillai, S., Avagyan, A., Wittig, B. M., Loddenkemper, C., Hamann, A., Hamelmann, E. H., Lucius, R., & Hartmann, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.4265 · Cited by 240
Critical Functions of the Lysosome in Cancer Biology
Davidson, S. M., & Heiden, M. G. V. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103101 · Cited by 214
Cystatin C: current position and future prospects
Séronie-Vivien, S., Delanaye, P., Piéroni, L., Mariat, C., Froissart, M., & Cristol, J. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.336 · Cited by 207
Glial influences on neural stem cell development: cellular niches for adult neurogenesis.
Ma, D.-K. K., Ming, G., & Song, H.-J. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.08.003 · Cited by 221
Cystatins in Immune System
Magister, Š., & Kos, J. (2013) · Journal of Cancer · doi:10.7150/jca.5044 · Cited by 199
Tumor immunoediting and immunosculpting pathways to cancer progression
Reiman, J. M., Kmieciak, M., Manjili, M. H., & Knutson, K. L. (2007) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2007.06.009 · Cited by 200
Involvement of cystatin C in immunity and apoptosis
Zi, M., & Xu, Y. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.01.006 · Cited by 170
Mechanisms for Asporin Function and Regulation in Articular Cartilage
Nakajima, M., Kizawa, H., Saitoh, M., Kou, I., Miyazono, K., & Ikegawa, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700522200 · Cited by 168
Fibulins 3 and 5 Antagonize Tumor Angiogenesis In vivo
Albig, A. R., Neil, J. R., & Schiemann, W. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4096 · Cited by 164
Self-citation
Cystatin Superfamily
Ochieng, J., & Chaudhuri, G. (2010) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.0.0257 · Cited by 161
Towards novel anti-cancer strategies based on cystatin function
Keppler, D. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.001 · Cited by 147
Cysteine Cathepsins in Tumor-Associated Immune Cells
Jakoš, T., Pišlar, A. H., Jewett, A., & Kos, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02037 · Cited by 145
Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells
Álvarez-Díaz, S., Valle, N., García, J. M., Peña, C., Freije, J. M. P., Quesada, V., Astudillo, A., Bonilla, F., López-Otín, C., & Múñoz, A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37205 · Cited by 135
A Helminth Immunomodulator Exploits Host Signaling Events to Regulate Cytokine Production in Macrophages
Klotz, C., Ziegler, T. R., Figueiredo, A. S., Rausch, S., Hepworth, M. R., Obsivac, N., Sers, C., Lang, R., Hammerstein, P., Lucius, R., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001248 · Cited by 130
Differential gene expression profiling of short and long term denervated muscle
Batt, J. A. E., Bain, J. R., Gonçalves, J., Michalski, B., Plant, P. J., Fahnestock, M. L., & Woodgett, J. R. (2005) · The FASEB Journal · doi:10.1096/fj.04-3640fje · Cited by 121
Cystatin C is a disease‐associated protein subject to multiple regulation
Xu, Y., Ding, Y., Li, X., & Wu, X. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2014.121 · Cited by 116
Hereditary Cystatin C Amyloid Angiopathy: Genetic, Clinical, and Pathological Aspects
Pálsdóttir, Á., Snorradóttir, Á. Ó., & Thorsteinsson, L. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00561.x · Cited by 112
Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
Wu, H., Du, Q., Dai, Q., Ge, J., & Cheng, X. W. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17016 · Cited by 111
Cystatins in cancer progression: More than just cathepsin inhibitors
Breznik, B., Mitrović, A., Lah, T. T., & Kos, J. (2019) · Biochimie · doi:10.1016/j.biochi.2019.05.002 · Cited by 106
Role of IL-10 in the progression of kidney disease
Sinuani, I., Beberashvili, I., Averbukh, Z., & Sandbank, J. (2013) · World Journal of Transplantation · doi:10.5500/wjt.v3.i4.91 · Cited by 102
Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics
Brown, R., Nath, S., Lora, A., Samaha, G., Elgamal, Z., Kaiser, R., Taggart, C., Weldon, S., & Geraghty, P. (2020) · Respiratory Research · doi:10.1186/s12931-020-01381-5 · Cited by 82
LncRNA Snhg1, a non-degradable sponge for miR-338, promotes expression of proto-oncogene CST3 in primary esophageal cancer cells
Yan, Y., Fan, Q., Wang, L., Zhou, Y., Li, J., & Zhou, K. (2017) · Oncotarget · doi:10.18632/oncotarget.16189 · Cited by 100
Lysyl Oxidase Contributes to Mechanotransduction-Mediated Regulation of Transforming Growth Factor-β Signaling in Breast Cancer Cells
Taylor, M. A., Amin, J., Kirschmann, D. A., & Schiemann, W. P. (2011) · Neoplasia · doi:10.1593/neo.101086 · Cited by 95
Self-citation
On the role of cystatin C in cancer progression
Leto, G., Crescimanno, M., & Flandina, C. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.013 · Cited by 84
Cystatin protease inhibitors and immune functions
Zavašnik‐Bergant, T. (2008) · Frontiers in bioscience · doi:10.2741/3028 · Cited by 83
The use of cystatin C to inhibit epithelial–mesenchymal transition and morphological transformation stimulated by transforming growth factor-β
Sokol, J. P., Neil, J. R., Schiemann, B. J., & Schiemann, W. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1312 · Cited by 80
Self-citation
Role of Transforming Growth Factor-β In Cancer Progression
Galliher, A. J., Neil, J. R., & Schiemann, W. P. (2006) · Future Oncology · doi:10.2217/14796694.2.6.743 · Cited by 80
Self-citation
Cystatin C: A New Renal Marker and Its Potential Use in Small Animal Medicine
Ghys, L. F. E., Paepe, D., Smets, P. M. Y., Lefebvre, H., Delanghe, J., & Daminet, S. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12366 · Cited by 82
Inhibitory properties of cystatin F and its localization in U937 promonocyte cells
Langerholc, T., Zavašnik‐Bergant, V., Turk, B., Türk, V., Abrahamson, M., & Kos, J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04594.x · Cited by 78
Mass spectrometric proteomics profiles of in vivo tumor secretomes: Capillary ultrafiltration sampling of regressive tumor masses
Huang, C., Ananthaswamy, H. N., Barnes, S., Ma, Y., Kawai, M., & Elmets, C. A. (2006) · PROTEOMICS · doi:10.1002/pmic.200600287 · Cited by 72
Association of Visceral and Subcutaneous Adiposity with Kidney Function
Young, J. A., Hwang, S., Sarnak, M. J., Hoffmann, U., Massaro, J. M., Levy, D. A., Benjamin, E. J., Larson, M. G., Vasan, R. S., O’Donnell, C. J., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02490508 · Cited by 71
Cathepsin L increases invasion and migration of B16 melanoma
Yang, Z. F., & Cox, J. L. (2007) · Cancer Cell International · doi:10.1186/1475-2867-7-8 · Cited by 70
Cystatins and cancer
James, L. C. (2009) · Frontiers in bioscience · doi:10.2741/3255 · Cited by 59
G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo
Toh, H. C., Sun, L. J., Soe, Y., Wu, Y., Phoon, Y. P., Chia, W. K., Wu, J., Wong, K., & Tan, P. B. O. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.03.509 · Cited by 58
Cystatin C Rescues Degenerating Neurons in a Cystatin B-Knockout Mouse Model of Progressive Myoclonus Epilepsy
Kaur, G., Mohan, P. S., Pawlik, M., DeRosa, S., Fajiculay, J., Che, S., GRUBB, A. O., Ginsberg, S. D., Nixon, R. A., & Levy, E. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100461 · Cited by 58
ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis
Reese, J. M., Bruinsma, E. S., Nelson, A. W., Chernukhin, I. V., Carroll, J. S., Li, Y., Subramaniam, M., Suman, V. J., Negron, V. C., Monroe, D. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1807751115 · Cited by 58
Association of biological age with health outcomes and its modifiable factors
Liu, W., You, J., Ge, Y., Wu, B., Zhang, Y., Chen, S., Zhang, Y.-R., Huang, S., Ma, L., Feng, J., et al. (2023) · Aging Cell · doi:10.1111/acel.13995 · Cited by 56
Novel Egg White–based 3-D Cell Culture System
Kaipparettu, B. A., Kuiatse, I., Chan, B. T.-Y., Kaipparettu, M. B., Lee, A. V., & Oesterreich, S. (2008) · BioTechniques · doi:10.2144/000112883 · Cited by 55
High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study
Magnusson, M., Hedblad, B., Engström, G., Persson, M., Nilsson, P. M., & Melander, O. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12051 · Cited by 55
Phosphoprotein Secretome of Tumor Cells as a Source of Candidates for Breast Cancer Biomarkers in Plasma
Zawadzka, A. M., Schilling, B., Cusack, M. P., Sahu, A. K., Drake, P. M., Fisher, S. J., Benz, C. C., & Gibson, B. W. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.035485 · Cited by 53
Is serum Cystatin-C a suitable marker of renal function in children?
Zaffanello, M., Franchini, M., & Fanos, V. (2007) · PubMed · Cited by 52
Macrophage responses to interferon-γ are dependent on cystatin C levels
Frendéus, K. H., Wallin, H., Janciauskiene, S., & Abrahamson, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.05.005 · Cited by 51
Reduction of Experimental Human Fibrosarcoma Lung Metastasis in Mice by Adenovirus-Mediated Cystatin C Overexpression in the Host
Kopitz, C., Anton, M., Gänsbacher, B., & Krüger, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1572 · Cited by 51
Serum levels of cystatin C in patients with malignancy
Nakai, K., Kikuchi, M., Fujimoto, K., Kaneko, Y., Omori, S., Nakai, K., & Suwabe, A. (2008) · Clinical and Experimental Nephrology · doi:10.1007/s10157-008-0043-8 · Cited by 50
IL-10 Controls Cystatin C Synthesis and Blood Concentration in Response to Inflammation through Regulation of IFN Regulatory Factor 8 Expression
Xu, Y., Schnorrer, P., Proietto, A. I., Kowalski, G. M., Febbraio, M. A., Acha‐Orbea, H., Dickins, R. A., & Villadangos, J. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001934 · Cited by 49
CST3 and GDF15 ameliorate renal fibrosis by inhibiting fibroblast growth and activation
Kim, Y.-I., Shin, H., Chun, Y., & Park, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.061 · Cited by 48
Cystatins – Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells
Wallin, H., Bjarnadóttir, M., Vogel, L. K., Wassélius, J., Ekström, U., & Abrahamson, M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.08.011 · Cited by 47
Cystatin F as a regulator of immune cell cytotoxicity
Kos, J., Nanut, M. P., Prunk, M., Sabotič, J., Dautović, E., & Jewett, A. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2165-5 · Cited by 46
Cystatin C as a p53‐inducible apoptotic mediator that regulates cathepsin L activity
Mori, J., Tanikawa, C., Funauchi, Y., Lo, P. H. Y., Nakamura, Y., & Matsuda, K. (2016) · Cancer Science · doi:10.1111/cas.12881 · Cited by 45
Epithelial cell-derived cytokines CST3 and GDF15 as potential therapeutics for pulmonary fibrosis
Kim, Y.-I., Shin, H., Chun, Y., Cho, C., Koh, J., Chung, D. H., & Park, J. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0530-0 · Cited by 43
Cystatins in non-small cell lung cancer: Tissue levels, localization and relation to prognosis
Werle, B., Schanzenbächer, U., Lah, T. T., Ebert, E., Jülke, B., Ébert, W., Fiehn, W., Kayser, K., Spieß, E., Abrahamson, M., et al. (2006) · Oncology Reports · doi:10.3892/or.16.4.647 · Cited by 42
Aging stem cells, latexin, and longevity
Liang, Y., & Zant, G. E. V. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.032 · Cited by 42
Different Cysteine Proteinases Involved in Bone Resorption and Osteoclast Formation
Brage, M., Abrahamson, M., Lindström, V., GRUBB, A. O., & Lerner, U. H. (2005) · Calcified Tissue International · doi:10.1007/s00223-004-0043-y · Cited by 41
Influence of Thyroid Hormones and Transforming Growth Factor-β1 on Cystatin C Concentrations
Kotajima, N., Yanagawa, Y., Aoki, T., Tsunekawa, K., Morimura, T., Ogiwara, T., Nara, M., & Murakami, M. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800418 · Cited by 41
Epigenetic regulation of cystatins in cancer
Ashley, G. R. (2009) · Frontiers in bioscience · doi:10.2741/3254 · Cited by 40
Moving from the Laboratory Bench to Patients’ Bedside: Considerations for Effective Therapy with Stem Cells
Sherman, L. S., Munoz, J. L., Patel, S. A., Dave, M. A., Paige, I., & Rameshwar, P. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00283.x · Cited by 39
Association Between Serum Cystatin C and Thyroid Diseases: A Systematic Review and Meta-Analysis
Xin, C., Xie, J., Fan, H., Sun, X., & Shi, B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.766516 · Cited by 39
Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon
Khalkhali‐Ellis, Z. (2014) · Biology and Medicine · doi:10.4172/0974-8369.1000206 · Cited by 41
Silencing of cystatin M in metastatic oral cancer cell line MDA-686Ln by siRNA increases cysteine proteinases and legumain activities, cell proliferation and in vitro invasion
Vigneswaran, N., Wu, J. G., Nagathihalli, N. S., James, R. I., Zeeuwen, P. L. J. M., & Zacharias, W. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.096 · Cited by 34
Syndecan‐2 is a key regulator of transforming growth factor beta 2/smad2‐mediated adhesion in fibrosarcoma cells
Mytilinaiou, M. G., Bano, A., Nikitovic, D., Berdiaki, A., Voudouri, K., Kalogeraki, A. M., Karamanos, N. K., & Tzanakakis, G. N. (2013) · IUBMB Life · doi:10.1002/iub.1112 · Cited by 33
Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling
Strålberg, F., Henning, P., Gjertsson, I., Kindlund, B., de Souza, P. C., Persson, E., Abrahamson, M., Kasprzykowski, F., GRUBB, A. O., & Lerner, U. H. (2013) · The FASEB Journal · doi:10.1096/fj.12-211748 · Cited by 33
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report
Leto, G., Incorvaia, L., Flandina, C., Ancona, C., Fulfaro, F., Crescimanno, M., Sepporta, M. V., & Badalamenti, G. (2016) · Cancer Investigation · doi:10.1080/07357907.2016.1222416 · Cited by 33
Cystatin C deficiency suppresses tumor growth in a breast cancer model through decreased proliferation of tumor cells
Završnik, J., Butinar, M., Prebanda, M. T., Krajnc, A., Vidmar, R., Fonovič, M., GRUBB, A. O., Türk, V., Turk, B., & Vasiljeva, O. S. (2017) · Oncotarget · doi:10.18632/oncotarget.17379 · Cited by 33
Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications
Tumminello, F. M., Flandina, C., Crescimanno, M., & Leto, G. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.07.001 · Cited by 32
Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target
Ferraro, S., Marano, G., Biganzoli, E. M., Boracchi, P., & Bongo, A. S. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.607 · Cited by 32
Identification of the Amyloid β-Protein Precursor and Cystatin C as Novel Epidermal Growth Factor Receptor Regulated Secretory Proteins in Nasopharyngeal Carcinoma by Proteomics
Tang, C., Guan, Y., Yi, B., Li, X., Liang, K., Zou, H., Yi, H. L., Li, M., Zhang, P., Li, C., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr100663p · Cited by 31
The protease inhibitor cystatin C down-regulates the release of IL-β and TNF-α in lipopolysaccharide activated monocytes
Gren, S. T., Janciauskiene, S. M., Salipalli, S., Jonigk, D. D., Kvist, P. H., Gerwien, J. G., Håkansson, K., & Grip, O. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0415-174r · Cited by 31
Clinicopathologic significance of cystatin C expression in gliomas
NAKABAYASHI, H., HARA, M., & Shimuzu, K. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.06.021 · Cited by 31
Cathepsin S and its inhibitor cystatin C: imbalance in uveal melanoma
Paraoan, L. (2009) · Frontiers in bioscience · doi:10.2741/3393 · Cited by 29
The candidate tumor suppressor CST6 alters the gene expression profile of human breast carcinoma cells: Down-regulation of the potent mitogenic, motogenic, and angiogenic factor autotaxin
Song, J., Jie, C., Polk, P., Shridhar, R., Clair, T., Zhang, J., Yin, L., & Keppler, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.171 · Cited by 29
Cerebral malaria: insights from host-parasite protein-protein interactions
Rao, A., Kumar, M. K., Joseph, T., & Bulusu, G. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-155 · Cited by 28
Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice
Yu, W., Liu, J., Shi, M. A., Wang, J., Xiang, M., Kitamoto, S., Wang, B., Sukhova, G. K., Murphy, G. F., Orasanu, G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013973 · Cited by 28
Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and Epithelial-Mesenchymal Transition
Tang, N., Xie, Q., Wang, X., Li, X., Chen, Y., Lin, X., & Lin, J. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0512-6 · Cited by 28
Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells
Rubis, G. D., Paudel, K. R., Liu, G., Agarwal, V., MacLoughlin, R. J., Pinto, T. D. J. A., Singh, S. K., Adams, J., Nammi, S., Chellappan, D. K., et al. (2023) · Toxicology in Vitro · doi:10.1016/j.tiv.2023.105660 · Cited by 27
Contribution of the MDRD Equation and of Cystatin C for Renal Function Estimates in Cancer Patients
Séronie-Vivien, S., Toullec, S., Malard, L., Thomas, F., Durrand, V., & Chatelut, É. (2006) · Medical Oncology · doi:10.1385/mo:23:1:63 · Cited by 27
Susceptibility to Salmonella carrier-state: A possible Th2 response in susceptible chicks
Chaussé, A., Grépinet, O., Bottreau, E., Robert, V., Hennequet‐Antier, C., Lalmanach, A.-C., Lecardonnel, J., Beaumont, C., & Velge, P. (2014) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2014.03.001 · Cited by 27
Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells
Wallin, H., Apelqvist, J., Andersson, F., Ekström, U., & Abrahamson, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.776138 · Cited by 26
Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma
Guo, S., Xue, Y., He, Q., He, X., Guo, K., Dong, P., Yao, K., Yang, G., Chen, D., Li, Z., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178823 · Cited by 26
Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression
Zhang, Z., & Zhan, F. (2023) · Cancers · doi:10.3390/cancers15225363 · Cited by 25
Preclinical Efficacy of Cystatin C to Target the Oncogenic Activity of Transforming Growth Factor β in Breast Cancer
Tian, M., & Schiemann, W. P. (2009) · Translational Oncology · doi:10.1593/tlo.09145 · Cited by 25
Self-citation
Isotope-coded protein label based quantitative proteomic analysis reveals significant up-regulation of apolipoprotein A1 and ovotransferrin in the myopic chick vitreous
Yu, F., Lam, T. C., Liu, L., Chun, R. K. M., Cheung, J. K.-W., Li, K. K., & To, C. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-12650-7 · Cited by 24
The potential of cystatin C as a predictive biomarker in breast cancer
Leto, G., & Sepporta, M. V. (2020) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2020.1829481 · Cited by 24
Natural cystatin C fragments inhibit GPR15-mediated HIV and SIV infection without interfering with GPR15L signaling
Hayn, M., Blötz, A., Rodríguez, A., Vidal, S., Preising, N., Ständker, L., Wiese, S., Stürzel, C. M., Harms, M., Groß, R. M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2023776118 · Cited by 25
Targeted TGF-β chemotherapies: friend or foe in treating human malignancies?
Schiemann, W. P. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.5.609 · Cited by 24
Self-citation
Aberrant cystatin‑C expression in blood from patients with breast cancer is a suitable marker for monitoring tumor burden
Kwon, W., Kim, T., Nahm, C., Moon, Y., & Kim, J. (2018) · Oncology Letters · doi:10.3892/ol.2018.9380 · Cited by 21
Detection of Cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits
Jiang, R., Xu, C., Zhou, X., Wang, T., & Yao, G. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-205 · Cited by 21
Genetics of epilepsy: Epilepsy Research Foundation workshop report
Sisodiya, S. M., Cross, J. H., Blümcke, I., Chadwick, D. W., Craig, J. J., Crino, P. B., Debenham, P., Delanty, N., Elmslie, F., Gardiner, M., et al. (2007) · Epileptic Disorders · doi:10.1684/epd.2007.0107 · Cited by 21
Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
Muto, H., Ohashi, K., Ando, M., Akiyama, H., & Sakamaki, H. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0521-0 · Cited by 20
Cystatins, cysteine peptidase inhibitors, as regulators of immune cell cytotoxicity
Prunk, M., Nanut, M. P., Sabotič, J., & Kos, J. (2017) · Periodicum Biologorum · doi:10.18054/pb.v118i4.4504 · Cited by 19
Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis
Moshe, A., Izraely, S., Sagi‐Assif, O., Prakash, R., Telerman, A., Meshel, T., Carmichael, S. T., & Witz, I. P. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9891-0 · Cited by 18
Expression and significance of Cystatin-C in clear cell renal cell carcinoma
Guo, K., Chen, Q., He, X., Yao, K., Li, Z., Liu, Z., Chen, J., Liu, Z., Guo, C., Lu, J., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.083 · Cited by 18
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer
Öztürk, H., Cingoz, H., Tufan, T., Yang, J., Adair, S. J., Tummala, K. S., Kuscu, C., Kinali, M., Cömertpay, G., Nagdas, S., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.04.014 · Cited by 18
Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine
Rademaker, M. T., Ellmers, L. J., Charles, C. J., & Richards, M. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.011 · Cited by 18
Structural Dynamics Investigation of Human Family 1 & 2 Cystatin-Cathepsin L1 Interaction: A Comparison of Binding Modes
Nandy, S. K., & Seal, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164970 · Cited by 17
Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells
Gressner, A. M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i5.731 · Cited by 16
Microcystin-LR-Induced Interaction between M2 Tumor-Associated Macrophage and Colorectal Cancer Cell Promotes Colorectal Cancer Cell Migration through Regulating the Expression of TGF-β1 and CST3
Jiang, X., Zhang, H., Zhang, H., Wang, F., Wang, X. C., Ding, T., Zhang, X., & Wang, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310527 · Cited by 15

Authors: Sokol, J. P., & Schiemann, W. P.
Affiliations: National Jewish Health (US)
ORCID: Schiemann, William P.
Venue: Molecular Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2004-03-01
Volume: 2
Issue: 3
Pages: 183-195
ISSN: 1541-7786 (ISSN-L)
1557-3125
DOI: 10.1158/1541-7786.183.2.3
OpenAlex: W4292964442
Cited by: 121
References: 60
Citations by year: 2026: 1 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 5 · 2019: 1 · 2018: 10 · 2017: 10 · 2016: 8 · 2015: 3 · 2014: 4 · 2013: 5 · 2012: 2
FWCI: 3.08
Type: journal article
Language: en
Open access: closed
Locations: Molecular Cancer Research (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords: cystatin C, TGF-beta, TGF-beta signaling, cathepsins, cysteine protease inhibitors, TGFBR2, cell invasion, fibroblasts, fibrosarcoma, cancer gene expression, tumor suppression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cystatin C Antagonizes Transforming Growth Factor β Signaling in Normal and Cancer Cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks